Treace to Report First Quarter 2023 Financial Results on May 8, 2023
April 20, 2023 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., April 20, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Medical Expands Market Leading Global IP Portfolio For Bunion And Related Deformities
April 19, 2023 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., April 19, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Publishes Inaugural ESG Report
April 04, 2023 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., April 04, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Medical Concepts Reports Fourth Quarter and Full Year 2022 Financial Results
March 07, 2023 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., March 07, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Medical Announces Settlement of Lawsuit Against Fusion Orthopedics
March 03, 2023 09:03 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., March 03, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in...
Treace to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
February 27, 2023 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Presents Updated ALIGN3D™ Interim Data and Latest Product Innovations at the 2023 ACFAS Annual Conference
February 09, 2023 13:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Medical Concepts, Inc. Announces Pricing of $100.0 Million Public Offering of Common Stock
February 07, 2023 21:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Medical Concepts, Inc. Announces Proposed Public Offering of Common Stock
February 07, 2023 16:30 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Medical Concepts Provides 2022 Preliminary Unaudited Revenue
January 09, 2023 08:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...